90 related articles for article (PubMed ID: 21238783)
1. Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study.
Paim CS; Führ F; Barth AB; Gonçalves CE; Nardi N; Steppe M; Schapoval EE
Talanta; 2011 Feb; 83(5):1774-9. PubMed ID: 21238783
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of besifloxacin ophthalmic suspension by HPLC, application to bioassay method and cytotoxicity studies.
Costa MC; Barden AT; Andrade JM; Oppe TP; Schapoval EE
Talanta; 2014 Feb; 119():367-74. PubMed ID: 24401427
[TBL] [Abstract][Full Text] [Related]
3. Highly selective colorimetric method to determine gemifloxacin mesylate in the presence of a synthetic impurity.
Paim CS; Führ F; Miron DS; Steppe M; Schapoval EE
J AOAC Int; 2014; 97(1):94-8. PubMed ID: 24672864
[TBL] [Abstract][Full Text] [Related]
4. Gemifloxacin mesylate (GFM): dissolution test based on in vivo data.
Paim CS; Verlindo de Araújo B; Volpato NM; Steppe M; Schapoval EE
Drug Dev Ind Pharm; 2015 Apr; 41(4):567-72. PubMed ID: 24517572
[TBL] [Abstract][Full Text] [Related]
5. Determination of gemifloxacin in different tissues of rat after oral dosing of gemifloxacin mesylate by LC-MS/MS and its application in drug tissue distribution study.
Roy B; Das A; Bhaumik U; Sarkar AK; Bose A; Mukharjee J; Chakrabarty US; Das AK; Pal TK
J Pharm Biomed Anal; 2010 Jun; 52(2):216-26. PubMed ID: 20092976
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability-indicative agar diffusion assay to determine the potency of linezolid in tablets in the presence of photodegradation products.
Lopes CC; Salgado HR
Talanta; 2010 Aug; 82(3):918-22. PubMed ID: 20678646
[TBL] [Abstract][Full Text] [Related]
7. Biological safety studies of gemifloxacin mesylate and related substances.
Paim CS; Nogueira DR; Mitjans M; Ramos Lopez D; de Lapuente Perez J; Steppe M; Schapoval EE; Vinardell MP
Photochem Photobiol Sci; 2013 May; 12(5):805-12. PubMed ID: 23361471
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a microbiological agar assay for determination of cefuroxime sodium in pharmaceutical preparations.
Schmidt CA; Agarrayua DA; Laporta LV; Machado JC; Manfio ML; Bittencourt CF
J Microbiol Methods; 2009 Jun; 77(3):308-15. PubMed ID: 19344741
[TBL] [Abstract][Full Text] [Related]
9. Microbiological assay for the determination of azithromycin in ophthalmic solutions.
Salgado HR; Roncari AF
Yao Xue Xue Bao; 2005 Jun; 40(6):544-9. PubMed ID: 16144322
[TBL] [Abstract][Full Text] [Related]
10. Structural elucidation of gemifloxacin mesylate degradation product.
Paim CS; Führ F; Martins MT; Gnoatto S; Bajerski L; Garcia CV; Steppe M; Schapoval EE
Biomed Chromatogr; 2016 Mar; 30(3):459-65. PubMed ID: 26205148
[TBL] [Abstract][Full Text] [Related]
11. Microbiological assay of ketoconazole in shampoo.
Staub I; Schapoval EE; Bergold AM
Int J Pharm; 2005 Mar; 292(1-2):195-9. PubMed ID: 15725566
[TBL] [Abstract][Full Text] [Related]
12. Microbiological assay for gatifloxacin in pharmaceutical formulations.
Salgado HR; Lopes CC; Lucchesi MB
J Pharm Biomed Anal; 2006 Feb; 40(2):443-6. PubMed ID: 16139980
[TBL] [Abstract][Full Text] [Related]
13. Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma.
Rote AR; Pingle SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3719-23. PubMed ID: 19716354
[TBL] [Abstract][Full Text] [Related]
14. Validated liquid chromatographic-fluorescence method for the quantitation of gemifloxacin in human plasma.
Al-Hadiya BM; Khady AA; Mostafa GA
Talanta; 2010 Nov; 83(1):110-6. PubMed ID: 21035650
[TBL] [Abstract][Full Text] [Related]
15. Microbiological assay for the determination of meropenem in pharmaceutical dosage form.
Mendez AS; Weisheimer V; Oppe TP; Steppe M; Schapoval EE
J Pharm Biomed Anal; 2005 Apr; 37(4):649-53. PubMed ID: 15797784
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability indicating HPLC method for simultaneous determination of four novel fluoroquinolone dimers as potential antibacterial agents.
Khan M; Reddy CN; Ravindra G; Reddy KV; Dubey PK
J Pharm Biomed Anal; 2012 Feb; 59():162-6. PubMed ID: 22030076
[TBL] [Abstract][Full Text] [Related]
17. Roxithromycin potency quantification in pharmaceutical preparation by applying a validated bioassay method and comparison with HPLC analysis.
Suke SG; Chahande AD; Kasliwal RH; Asnani AJ
Ann Pharm Fr; 2015 Sep; 73(5):340-50. PubMed ID: 26021576
[TBL] [Abstract][Full Text] [Related]
18. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.
Huang X; Zhang A; Chen D; Jia Z; Li X
Bioorg Med Chem Lett; 2010 May; 20(9):2859-63. PubMed ID: 20347299
[TBL] [Abstract][Full Text] [Related]
19. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
Vadera N; Subramanian G; Musmade P
J Pharm Biomed Anal; 2007 Jan; 43(2):722-6. PubMed ID: 16920319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
